Please ensure Javascript is enabled for purposes of website accessibility
Your free article limit has been reached this month.

OPINION: Ivermectin II: Cons and pros

Readers chastised us, saying we were promoting a COVID-19 drug that’s dangerous and unproven. Dr. Pierre Kory addresses those concerns.


  • By Matt Walsh
  • | 6:10 a.m. September 8, 2021
  • | 0 Free Articles Remaining!
  • Opinion
  • Share

Two weeks ago, we published on this page our urging to readers to read a long magazine article on the use of the drug ivermectin to treat COVID-19 — “The Drug That Cracked COVID.” You can read it at rescue.substack.com.

Written by New York Times bestselling author and journalist Michael Capuzzo for his and his wife Teresa’s Pennsylvania magazine, Mountain Home, the article chronicled the struggles of renowned academic medical researchers and physicians Drs. Pierre Kory and Paul Malik and others to convince public health agencies in the U.S. and around the world of the efficacy of ivermectin in the treatment of COVID-19 and that this FDA-approved, generic drug should be authorized for doctors to prescribe.

 


Your Business News. Your Way.

Subscribe today. Cancel anytime.

author

Matt Walsh

Matt Walsh is the CEO and founder of Observer Media Group.

Latest News

×

Special Offer: Only $1 Per Week For 1 Year!

Your free article limit has been reached this month.
Subscribe now for unlimited digital access to our award-winning business news.
Join thousands of executives who rely on us for insights spanning Tampa Bay to Naples.